{"id":"https://openalex.org/W7225252640","doi":"https://doi.org/10.1002/cnr2.70726","title":"Pembrolizumab Activity in Tyrosine Kinase Inhibitor\u2013Refractory Metastatic GIST : A Case Report","display_name":"Pembrolizumab Activity in Tyrosine Kinase Inhibitor\u2013Refractory Metastatic GIST : A Case Report","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225252640","doi":"https://doi.org/10.1002/cnr2.70726","pmid":"https://pubmed.ncbi.nlm.nih.gov/42981503","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13734685"},"language":"en","primary_location":{"id":"doi:10.1002/cnr2.70726","doi":"https://doi.org/10.1002/cnr2.70726","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cnr2.70726","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cnr2.70726","source":{"id":"https://openalex.org/S4210241191","display_name":"Cancer Reports","issn_l":"2573-8348","issn":["2573-8348"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Reports","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cnr2.70726","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160605749","display_name":"Neharika Bandaru","orcid":"https://orcid.org/0009-0002-1570-2729","observed_orcids":["https://orcid.org/0009-0002-1570-2729"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I4210117038","display_name":"USC Norris Comprehensive Cancer Center","ror":"https://ror.org/01nmyfr60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800154431","https://openalex.org/I4210117038"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neharika Bandaru","raw_affiliation_strings":["USC Norris Comprehensive Cancer Center Keck School of Medicine of the University of Southern California  Los Angeles California USA"],"raw_orcid":"https://orcid.org/0009-0002-1570-2729","affiliations":[{"raw_affiliation_string":"USC Norris Comprehensive Cancer Center Keck School of Medicine of the University of Southern California  Los Angeles California USA","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I4210117038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083036954","display_name":"Job Shiach","orcid":"https://orcid.org/0000-0002-6518-9663","observed_orcids":["https://orcid.org/0000-0002-6518-9663"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I4210117038","display_name":"USC Norris Comprehensive Cancer Center","ror":"https://ror.org/01nmyfr60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800154431","https://openalex.org/I4210117038"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Job Shiach","raw_affiliation_strings":["Department of Internal Medicine Keck School of Medicine of the University of Southern California  Los Angeles California USA","Los Angeles General Medical Center  Los Angeles California USA","USC Norris Comprehensive Cancer Center Keck School of Medicine of the University of Southern California  Los Angeles California USA"],"raw_orcid":"https://orcid.org/0000-0002-6518-9663","affiliations":[{"raw_affiliation_string":"Department of Internal Medicine Keck School of Medicine of the University of Southern California  Los Angeles California USA","institution_ids":["https://openalex.org/I1174212"]},{"raw_affiliation_string":"Los Angeles General Medical Center  Los Angeles California USA","institution_ids":[]},{"raw_affiliation_string":"USC Norris Comprehensive Cancer Center Keck School of Medicine of the University of Southern California  Los Angeles California USA","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I4210117038"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031405616","display_name":"Mark Agulnik","orcid":"https://orcid.org/0000-0003-3513-3519","observed_orcids":["https://orcid.org/0000-0003-3513-3519"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I4210117038","display_name":"USC Norris Comprehensive Cancer Center","ror":"https://ror.org/01nmyfr60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800154431","https://openalex.org/I4210117038"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Agulnik","raw_affiliation_strings":["USC Norris Comprehensive Cancer Center Keck School of Medicine of the University of Southern California  Los Angeles California USA"],"raw_orcid":"https://orcid.org/0000-0003-3513-3519","affiliations":[{"raw_affiliation_string":"USC Norris Comprehensive Cancer Center Keck School of Medicine of the University of Southern California  Los Angeles California USA","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I4210117038"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5083036954"],"corresponding_institution_ids":["https://openalex.org/I1174212","https://openalex.org/I4210117038"],"apc_list":{"value":3280,"currency":"USD","value_usd":3280},"apc_paid":{"value":3280,"currency":"USD","value_usd":3280},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.86012208,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"9","issue":"11","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11485","display_name":"Gastrointestinal Tumor Research and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11485","display_name":"Gastrointestinal Tumor Research and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9660000205039978},{"id":"https://openalex.org/keywords/gastrointestinal-stromal-tumor","display_name":"gastrointestinal stromal tumor","score":0.9589999914169312},{"id":"https://openalex.org/keywords/metastatic-gist","display_name":"metastatic GIST","score":0.9300000071525574},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitor-resistance","display_name":"tyrosine kinase inhibitor resistance","score":0.9309999942779541},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.7379999756813049},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.949999988079071},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.8809999823570251},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.8410000205039978},{"id":"https://openalex.org/keywords/stable-disease","display_name":"stable disease","score":0.4560000002384186}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.9236999750137329},{"id":"https://openalex.org/C2775922572","wikidata":"https://www.wikidata.org/wiki/Q83567","display_name":"GiST","level":3,"score":0.8515999913215637},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8447999954223633},{"id":"https://openalex.org/C2777007597","wikidata":"https://www.wikidata.org/wiki/Q16869243","display_name":"Stromal tumor","level":3,"score":0.6466000080108643},{"id":"https://openalex.org/C2776248978","wikidata":"https://www.wikidata.org/wiki/Q3891664","display_name":"Regorafenib","level":4,"score":0.5697000026702881},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5177000164985657},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.47780001163482666},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4731000065803528},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4580000042915344},{"id":"https://openalex.org/C37307934","wikidata":"https://www.wikidata.org/wiki/Q18030422","display_name":"PDGFRA","level":4,"score":0.45019999146461487},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.4438999891281128},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.41519999504089355},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.40799999237060547},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.39489999413490295},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.3603000044822693},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.359499990940094},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.3580000102519989},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.349700003862381},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3456000089645386},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.32739999890327454},{"id":"https://openalex.org/C36823959","wikidata":"https://www.wikidata.org/wiki/Q373027","display_name":"Exon","level":3,"score":0.3111000061035156},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.30309998989105225},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.2989000082015991},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.2930999994277954},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.28299999237060547},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.2646999955177307},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2605000138282776},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.2547999918460846}],"mesh":[{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005770","descriptor_name":"Gastrointestinal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005770","descriptor_name":"Gastrointestinal Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D005770","descriptor_name":"Gastrointestinal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019009","descriptor_name":"Proto-Oncogene Proteins c-kit","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D046152","descriptor_name":"Gastrointestinal Stromal Tumors","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D046152","descriptor_name":"Gastrointestinal Stromal Tumors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D046152","descriptor_name":"Gastrointestinal Stromal Tumors","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1002/cnr2.70726","doi":"https://doi.org/10.1002/cnr2.70726","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cnr2.70726","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cnr2.70726","source":{"id":"https://openalex.org/S4210241191","display_name":"Cancer Reports","issn_l":"2573-8348","issn":["2573-8348"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Reports","raw_type":"journal-article"},{"id":"pmid:42981503","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42981503","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer reports (Hoboken, N.J.)","raw_type":"Case Reports"},{"id":"pmh:oai:pubmedcentral.nih.gov:13734685","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13734685/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Rep (Hoboken)","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1002/cnr2.70726","doi":"https://doi.org/10.1002/cnr2.70726","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cnr2.70726","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cnr2.70726","source":{"id":"https://openalex.org/S4210241191","display_name":"Cancer Reports","issn_l":"2573-8348","issn":["2573-8348"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225252640.pdf","grobid_xml":"https://content.openalex.org/works/W7225252640.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W2015015957","https://openalex.org/W2019607817","https://openalex.org/W2103304755","https://openalex.org/W2106631163","https://openalex.org/W2178731684","https://openalex.org/W3180857245","https://openalex.org/W4411441774"],"related_works":["https://openalex.org/W3000551131","https://openalex.org/W1984526155","https://openalex.org/W4292087206","https://openalex.org/W4226404357","https://openalex.org/W2113485288","https://openalex.org/W2146306052","https://openalex.org/W2413248064","https://openalex.org/W1991113818","https://openalex.org/W2044711703","https://openalex.org/W3118236671"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Gastrointestinal":[1],"stromal":[2],"tumors":[3],"(GISTs)":[4],"are":[5],"commonly":[6],"driven":[7],"by":[8],"activating":[9],"mutations":[10],"in":[11,24,37,176],"KIT":[12,77,84],"or":[13,108,155],"PDGFRA.":[14],"Although":[15],"sequential":[16],"tyrosine":[17],"kinase":[18],"inhibitors":[19],"(TKIs)":[20],"have":[21,39],"improved":[22],"outcomes":[23],"advanced":[25],"disease,":[26],"acquired":[27],"resistance":[28],"is":[29,45,198],"common.":[30],"Prospective":[31],"studies":[32],"of":[33,173],"immune":[34,187],"checkpoint":[35],"blockade":[36],"GIST":[38,61,180],"shown":[40],"limited":[41],"activity,":[42],"and":[43,89,103,128,189,200],"immunotherapy":[44],"not":[46,202],"a":[47,75,82,96],"standard":[48],"treatment.":[49],"CASE":[50],"PRESENTATION:":[51],"A":[52],"man":[53],"diagnosed":[54],"at":[55,169],"age":[56],"57":[57],"with":[58,168],"epithelioid":[59],"small-bowel":[60],"developed":[62],"hepatic":[63],"metastatic":[64,179],"disease":[65,139,174],"7":[66],"years":[67,126],"after":[68,181],"his":[69],"initial":[70],"diagnosis.":[71],"His":[72],"tumor":[73,98,210],"harbored":[74],"primary":[76],"exon":[78,85],"11":[79],"D579del":[80],"mutation,":[81,88],"secondary":[83],"17":[86],"D820G":[87],"CDKN2A/CDKN2B":[90],"deletions;":[91],"available":[92],"molecular":[93],"testing":[94],"reported":[95,160],"low":[97],"mutational":[99],"burden":[100],"(1":[101],"mutation/Mb)":[102],"microsatellite-stable":[104,178],"disease.":[105],"After":[106],"progression":[107],"treatment-limiting":[109],"toxicity":[110],"during":[111],"six":[112,182],"TKI":[113,183,206],"regimens,":[114],"pembrolizumab":[115],"was":[116,124,145,166],"initiated":[117],"on":[118,140,148],"October":[119],"28,":[120,150],"2025,":[121],"when":[122],"he":[123],"76":[125],"old,":[127],"administered":[129,147],"intravenously":[130],"every":[131],"3":[132],"weeks.":[133],"The":[134],"treatment":[135,153],"has":[136],"demonstrated":[137],"stable":[138],"CT":[141],"imaging;":[142],"cycle":[143,162],"13":[144],"then":[146],"July":[149],"2026.":[151],"No":[152],"delays":[154],"treatment-related":[156],"adverse":[157],"events":[158],"were":[159,194],"through":[161],"13.":[163],"CONCLUSION:":[164],"Pembrolizumab":[165],"associated":[167],"least":[170],"9":[171],"months":[172],"control":[175],"TMB-low,":[177],"regimens.":[184],"Because":[185],"contemporaneous":[186],"profiling":[188],"complete":[190],"historical":[191],"dosing":[192],"data":[193],"unavailable,":[195],"this":[196],"observation":[197],"hypothesis-generating":[199],"does":[201],"establish":[203],"that":[204],"prior":[205],"exposure":[207],"sensitized":[208],"the":[209],"to":[211],"PD-1":[212],"blockade.":[213]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-05T00:00:00"}